Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Steroid-responsive multifocal demyelinating neuropathy with central involvement.

R Liguori1, R Rizzi, R Vetrugno

  • 1Institute of Neurology, University of Bologna, Italy.

Muscle & Nerve
|February 19, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Women and multiple sclerosis: From gender medicine to precision medicine.

Multiple sclerosis and related disorders·2025
Same author

Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study.

Multiple sclerosis and related disorders·2024
Same author

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

Journal of medical economics·2023
Same author

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2022
Same author

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC medical research methodology·2022
Same author

Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis.

European journal of neurology·2020

Two patients with central and peripheral demyelination improved with steroid therapy. This condition affects the nervous system, causing nerve damage and impacting motor and sensory functions.

Area of Science:

  • Neuroscience
  • Neurology
  • Clinical Medicine

Background:

  • Demyelinating diseases can affect both the central and peripheral nervous systems.
  • Understanding the interplay between central and peripheral demyelination is crucial for diagnosis and treatment.

Observation:

  • Two patients presented with concurrent central and peripheral nervous system demyelination.
  • Clinical presentation included sensory and motor deficits.
  • Electrophysiological studies indicated a demyelinating polyneuropathy with conduction blocks.

Findings:

  • Abnormalities were noted in visual evoked potentials and motor evoked potentials, suggesting central nervous system involvement.
  • Magnetic resonance imaging revealed demyelinating lesions in the brain and spinal cord.

Related Experiment Videos

  • Sural nerve biopsy confirmed a demyelinating neuropathy.

    • Implications:

    • Steroid therapy led to clinical and electrophysiological improvement in both patients.
    • This suggests a potential therapeutic response to steroids in cases of combined central and peripheral demyelination.
    • Further research into the mechanisms and treatment of such conditions is warranted.